Form 4: GeneDx Holdings Corp. Director Acquires Shares Through Restricted Stock Unit Vesting

Richard C. Pfenniger Jr., a director of GeneDx Holdings Corp., acquired 918 shares of Class A Common Stock on May 2, 2025, through the vesting of restricted stock units.

Summary

• On May 2, 2025, Richard C. Pfenniger Jr., a director of GeneDx Holdings Corp., acquired 918 shares of Class A Common Stock.
• The acquisition was a result of the vesting of restricted stock units (RSUs).
• Each RSU represents the right to receive one share of the Issuer's Class A Common Stock upon settlement at no cost.
• The RSUs vest in three annual installments, starting May 2, 2023, contingent upon the director's continued service to the Issuer.
• Following the transaction, Pfenniger directly owns 28,582 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and insider alignment with company performance.

Positives

• The vesting of RSUs indicates a continued alignment of the director's interests with those of the company and its shareholders.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.

Key Dates

Keywords

GeneDx Holdings Corp., Director, Richard C. Pfenniger Jr., Class A Common Stock, Restricted Stock Units, RSU, Vesting, Beneficial Ownership, Form 4